Trial intelligence / Profile preview

Naltrexone for compulsive sexual behavior in adult heterosexual men

2016-002161-56Phase 4Completed

Sponsor
Mateusz Gola
Start
Aug 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, single-arm trial of naltrexone in hypersexuality, sponsored by Mateusz Gola. Primary endpoints: Change in Sex Addiction Screening Test (SAST) score, Change in Sexual Arousability Inventory (SAI) score and 2 more. Started Aug 2016; status: completed.

02

Drugs

naltrexone
03

Conditions

hypersexuality

Beyond the preview

Go deeper on 2016-002161-56.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-002161-56.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call